Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
Annualized revenue (TTM) · by quarter, last 36
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 8% | 6.7% | 17.7pp | 10 of 35 | 12 |
| EPSEPS | 13.8% | 14.5% | 197.0pp | 15 of 33 | 12 |
| Op cash flowOperating cash flow | 3.1% | 11.5% | 213.9pp | 10 of 29 | 10 |
| EBITDAEBITDA | 9.6% | 16.3% | 24.4pp | 13 of 33 | 12 |
| FCFFree cash flow | 2.3% | — | — | — | — |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: NVT on the compounders surface · All compounders, ranked